TDOC logo

TDOC
Teladoc Health Inc

40,908
Mkt Cap
$1.44B
Volume
10,790.00
52W High
$15.21
52W Low
$6.35
PE Ratio
-6.36
TDOC Fundamentals
Price
$8.14
Prev Close
$8.63
Open
$8.51
50D MA
$8.24
Beta
1.73
Avg. Volume
10.39M
EPS (Annual)
-$5.87
P/B
1.04
Rev/Employee
$467,195.27
Loading...
Loading...
News
all
press releases
Teladoc (TDOC) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·6d ago
News Placeholder
More News
News Placeholder
Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates
Teladoc (TDOC) delivered earnings and revenue surprises of +19.23% and +0.23%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
Wall Street's Insights Into Key Metrics Ahead of Teladoc (TDOC) Q3 Earnings
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Teladoc (TDOC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Zacks·7d ago
News Placeholder
GeneDx Holdings Corp. (WGS) Q3 Earnings and Revenues Surpass Estimates
GENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of +75.00% and +12.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
Teladoc (TDOC) Soars 10.0%: Is Further Upside Left in the Stock?
Teladoc (TDOC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Zacks·8d ago
News Placeholder
Teladoc Stock Shot Up 8% Today: BofA Views It As Differentiated Asset But Remains Cautious On Near-Term Outlook
Stocktwits·11d ago
News Placeholder
Organon (OGN) Earnings Expected to Grow: Should You Buy?
Organon (OGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·12d ago
News Placeholder
Teladoc (TDOC) Expected to Beat Earnings Estimates: Should You Buy?
Teladoc (TDOC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·13d ago
News Placeholder
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
In the most recent trading session, Teladoc (TDOC) closed at $8.53, indicating a -5.43% shift from the previous trading day.
Zacks·18d ago
News Placeholder
Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?
DHR gears up for Q3 results with steady earnings estimates and mixed segment trends across Life Sciences, Biotechnology and Diagnostics.
Zacks·18d ago

Latest TDOC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.